CAVAZZANA, ILARIA
 Distribuzione geografica
Continente #
EU - Europa 4.577
NA - Nord America 4.137
AS - Asia 775
AF - Africa 9
SA - Sud America 6
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 2
Totale 9.510
Nazione #
US - Stati Uniti d'America 4.121
IT - Italia 3.020
CN - Cina 528
UA - Ucraina 472
DE - Germania 297
HK - Hong Kong 175
FR - Francia 162
IE - Irlanda 161
GB - Regno Unito 146
FI - Finlandia 145
RU - Federazione Russa 37
IN - India 30
SE - Svezia 30
RO - Romania 18
ES - Italia 17
BE - Belgio 15
CA - Canada 15
SG - Singapore 12
NL - Olanda 9
CH - Svizzera 8
PL - Polonia 8
VN - Vietnam 8
MK - Macedonia 7
EG - Egitto 6
TR - Turchia 6
LU - Lussemburgo 5
AT - Austria 4
EU - Europa 4
GR - Grecia 4
IL - Israele 3
IR - Iran 3
SI - Slovenia 3
AU - Australia 2
BR - Brasile 2
DK - Danimarca 2
JO - Giordania 2
PH - Filippine 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AR - Argentina 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
CL - Cile 1
CO - Colombia 1
CY - Cipro 1
DZ - Algeria 1
EE - Estonia 1
FK - Isole Falkland (Malvinas) 1
ID - Indonesia 1
JP - Giappone 1
MS - Montserrat 1
MU - Mauritius 1
NO - Norvegia 1
UG - Uganda 1
Totale 9.510
Città #
Fairfield 640
Woodbridge 400
Jacksonville 377
Ashburn 323
Houston 292
Seattle 252
Cambridge 235
Wilmington 216
Princeton 189
Ann Arbor 186
Hong Kong 174
Chandler 164
Milan 164
Beijing 128
Rome 126
Nanjing 122
New York 115
Helsinki 109
Dublin 99
Florence 89
Brescia 55
Trieste 50
Nanchang 40
Des Moines 36
Turin 36
San Diego 34
Udine 34
Hebei 32
Lancaster 32
Shenyang 32
Verona 30
Padova 28
Genoa 27
Tianjin 27
Bologna 25
Shanghai 25
Dearborn 24
Genova 23
Bergamo 22
Changsha 22
London 22
Syracuse 21
Menlo Park 20
Pisa 20
Jinan 19
Reggio Nell'emilia 18
Jiaxing 16
San Francisco 16
Torino 16
Brussels 15
Redwood City 15
Trento 14
Mumbai 13
Modena 12
Toronto 12
Bari 11
Ferrara 11
Cosenza 10
Desio 10
Hangzhou 10
Kunming 10
Los Angeles 10
Orange 10
Pozzuolo Del Friuli 10
Sassari 10
Washington 10
Ningbo 9
Rho 9
Turriaco 9
Venice 9
Dong Ket 8
Fiumicino 8
Francenigo 8
Naples 8
Napoli 8
Norwalk 8
Nürnberg 8
Perugia 8
Cagliari 7
Catania 7
Dallas 7
Lecco 7
Manresa 7
Palermo 7
Pune 7
Boardman 6
Bucharest 6
Cairo 6
Caserta 6
Cernobbio 6
Cervignano del Friuli 6
Duncan 6
Montegranaro 6
Pescara 6
Piemonte 6
Pordenone 6
Prato 6
Sesto San Giovanni 6
Stra 6
Taizhou 6
Totale 5.634
Nome #
ANTICORPI ANTI-TH/TO NELLA SCLEROSI SISTEMICA (SSC): CORRELAZIONI CLINICHE E IMMUNOLOGICHE 1.956
ANTICORPI ANTI-RNA POLIMERASI III: UN MARKER DI ESORDIO PRECOCE DI SCLEROSI SISTEMICA 1.381
Anti-cyclic citrullinated peptide antibodies in systemic lupus erythematosus patients with articular involvement: a predictive marker for erosive disease? 148
Anti-RNA polymerase III antibodies as a risk marker for early Gastric Antral Vascular Ectasia (GAVE) in systemic sclerosis 137
Anti-RNA polymerase III antibodies: A marker of systemic sclerosis with rapid onset and skin thickening progression 126
Malignancies in Italian patients with systemic sclerosis positive for anti-RNA polymerase III antibodies 118
Endothelial dysfunction in early systemic lupus erythematosus patients and controls without previous cardiovascular events 117
Anti-argonaute2 (Ago2/Su) and -Ro antibodies identified by immunoprecipitation in primary anti-phospholipid syndrome (PAPS). 116
Macrophage activation syndrome in adult systemic lupus erythematosus: Report of seven adult cases from a single Italian rheumatology center 116
Anti-MJ/NXP-2 autoantibody specificity in a cohort of adult Italian patients with polymyositis/dermatomyositis. 113
The clinico-serological spectrum of overlap myositis 113
Serum Jo-1 Autoantibody and Isolated Arthritis in the Antisynthetase Syndrome: Review of the Literature and Report of the Experience of AENEAS Collaborative Group 112
C9orf72 Intermediate Alleles in Patients with Amyotrophic Lateral Sclerosis, Systemic Lupus Erythematosus, and Rheumatoid Arthritis 112
Autoantibodies' titre modulation by anti-BlyS treatment in systemic lupus erythematosus. 109
Endothelial Dysfunction In Early Systemic Lupus Erythematosus Patients And Controls Without Previous Cardiovascular Events. 108
Endothelium and the brain in CNS lupus. 106
Aortic stiffness and left ventricular hypertrophy in rheumatoid arthritis: Comment on the article by Rudominer et al. 102
Anti-Th/To are common antinucleolar autoantibodies in Italian patients with scleroderma. 101
Myositis-specific autoantibodies and their association with malignancy in Italian patients with polymyositis and dermatomyositis 100
COVID-19 in patients with rheumatic diseases in northern Italy: a single-centre observational and case–control study 100
Are the autoimmune/inflammatory syndrome induced by adjuvants (ASIA) and the undifferentiated connective tissue disease (UCTD) related to each other? A case-control study of environmental exposures 98
The 2016 classification criteria for primary Sjogren's syndrome: What's new? 98
Renal Involvement in Primary Antiphospholipid Syndrome: Retrospective Analysis of 160 Patients. 96
METODICHE AUTOMATIZZATE PER ANTICORPI ANTINUCLEO (ANA): E' POSSIBILE SOSTITUIRE L'IMMUNOFLUORESCENZA INDIRETTA? 94
The Clinical and Histological Spectrum of Idiopathic Inflammatory Myopathies. 94
Risk of congenital complete heart block in newborns of mothers with anti-Ro/SSA antibodies detected by counterimmunoelectrophoresis: a prospective study of 100 women 94
Autoantibodies and Skin Involvement in Systemic Autoimmune Diseases 91
[Neonatal lupus: clinical features and risk of congenital cardiac heart block in newborns from mothers with anti Ro/SSA antibodies] 90
Clinical follow-up predictors of disease pattern change in anti-Jo1 positive anti-synthetase syndrome: Results from a multicenter, international and retrospective study 89
Primary biliary cirrhosis-related autoantibodies in a large cohort of italian patients with systemic sclerosis 87
International cohort study of 73 anti-Ku-positive patients: Association of p70/p80 anti-Ku antibodies with joint/bone features and differentiation of disease populations by using principal-components analysis 87
Anti-Ro/SSA and La/SSB antibodies 87
Autoantibodies to survival of motor neuron complex in patients with polymyositis: Immunoprecipitation of D, E, F, and G proteins without other components of small nuclear ribonucleoproteins 85
Serum prealbumin is an independent predictor of mortality in systemic sclerosis outpatients 83
Anti-topoisomerase-I antibodies in systemic lupus erythematosus and potential association with the presence of anti-dsDNA antibodies 83
Update on Antiphospholipid Syndrome: Ten Topics in 2017 83
Evaluation of a novel particle-based assay for detection of autoantibodies in idiopathic inflammatory myopathies. 83
Serologic profile and mortality rates of scleroderma renal crisis in Italy 82
Rheumatoid arthritis and diabetes mellitus: Two faces of one coin? Comment on the article by Peters et al 79
Influence of Antisynthetase Antibodies Specificities on Antisynthetase Syndrome Clinical Spectrum Time Course. 77
Complement Activation and Pregnancy Failure. 76
Diastolic dysfunction in rheumatoid arthritis: a usual travel-mate? 74
LUPUS ERITEMATOSO SISTEMICO AD ESORDIO TARDIVO: CARATTERISTICHE CLINICHE ED IMMUNOLOGICHE 72
Complement cascade in systemic lupus erythematosus: Analyses of the three activation pathways 67
Intravenous cyclophosphamide for interstitial lung disease associated to systemic sclerosis: results with an 18-month long protocol including a maintenance phase 67
CLINICAL AND IMMUNOLOGICAL ASSOCIATION WITH AUTOANTIBODIES TO CELLULAR ANTIGEN IN A COHORT OF 532 SLE PATIENTS FROM A SINGLE CENTER 65
Reference standards for the detection of anti-mitochondrial and anti-rods/rings autoantibodies 64
Predictive Features and Clinical Presentation of Interstitial Lung Disease in Inflammatory Myositis 63
AUMENTO DELLA PROTEINA C-REATTIVA, ANTICORPI ANTI-CCP E FATTORE REUMATOIDE NELL'ARTRITE LUPICA 61
Una rara causa di shock cardiogeno in una giovane donna. 61
Rare Autoantibodies To Cellular Antigens In Systemic Lupus Erythematosous. 61
Ten Year Risk of Cardiovascular Events during anti-TNF Alpha in Rheumatoid Arthritis Patients 59
Analysis of C9Orf72 Expansions in Patients with Systemic Lupus Erythematosus and Rheumatoid Arthritis: Preliminary Data 59
A prospective evaluation of endothelial dysfunction in systemic Lupus Erythematosus patients without previous cardiovascular events: preliminary results 57
Comparison of early and late onset systemic lupus erythematosus 56
Systematic Review and Meta-analysis on the Association of Occupational Exposure to Free Crystalline Silica and Rheumatoid Arthritis 55
Left ventricular function in rheumatoid arthritis during anti-TNF-α treatment: a speckle tracking prospective echocardiographic study. 54
FIRST REPORT OF ANTI-MDA5 ANTIBODIES IN A COHORT OF ITALIAN PATIENTS WITH DERMATOMYOSITIS: CLINICAL AND SEROLOGIC CORRELATIONS 54
INTERESSAMENTO RENALE NELLA SINDROME DA ANTI-FOSFOLIPIDI PRIMARIA 53
A prospective evaluation of endothelial dysfunction in Systemic Lupus Erythematosus patients without previous cardiovascular events: preliminary results. 53
CONNETTIVITE INDIFFERENZIATA (UCTD) DI RECENTE DIAGNOSI: PROFILO CLINICO ED IMMUNOLOGICO 52
Renal involvement in primary anti-phospholipid syndrome 52
ANTI-RNA POLYMERASE III ANTIBODIES AS A RISK MARKER FOR EARLY DEVELOPMENT OF GASTRIC ANTRAL VASCULAR ECTASIA IN SYSTEMIC SCLEROSIS 50
ANTICORPI ANTI-SU NELLA SINDROME DA ANTICORPI ANTI-FOSFOLIPIDI PRIMARIA (PAPS) 50
DETECTION OF ANTI-ARGONAUTE2 (AGO2/SU) AND -RO ANTIBODIES BY IMMUNOPRECIPITATION, IN PRIMARY ANTI-PHOSPHOLIPID SYNDROME (PAPS) PATIENTS: ARE THEY PREDICTIVE FOR EVOLUTION IN SYSTEMIC LUPUS ERYTHEMATOSUS? 49
[TNF-alpha inhibition in anti-Ro/SSA positive patients with rheumatoid arthritis: clinical and immunologic effects] 49
Anti-carbamylated protein antibodies as a clinical response predictor in rheumatoid arthritis patients treated with abatacept 47
Anti-Ku antibodies in connective tissue diseases: clinical and serological evaluation of 14 patients 47
Antibodies against antigens related to Scleroderma in a cohort of patients with Morphea 45
Absent or suboptimal response to booster dose of COVID-19 vaccine in patients with autoimmune systemic diseases 44
LEFT VENTRICULAR FUNCTION IN RHEUMATOID ARTHRITIS DURING ANTI-TNF ALPHA TREATMENT: PROSPECTIVE STUDY 41
Left ventricular Systolic and diastolic function in rheumatoid arthritis 39
Left ventricular sistoli and diastolic function in outpatients affetected by rheumatoid arthritis 39
Studio ecocardiografico in pazienti affetti da artrite reumatoide. 38
The IMMENSE Study: The Interplay Between iMMune and ENdothelial Cells in Mediating Cardiovascular Risk in Systemic Lupus Erythematosus 38
STUDIO ECOCARDIOGRAFICO IN PAZIENTI AFFETTI DA ARTRITE REUMATOIDE 37
Left ventricular sistolic and diastolic function in rheumatoid arthritis. 36
Covid-19 And Rheumatic Autoimmune Systemic Diseases: Role of Pre-Existing Lung Involvement and Ongoing Treatments 36
Timing of onset affects arthritis presentation pattern in antisyntethase syndrome 35
Early echocardiographic alterations in SSc with anti-RNA polymerase III antibodies 34
Hepatitis C virus infection and primary Sjögren's Syndrome: A clinical and serologic description of 9 patients 34
Idiopathic inflammatory myopathies: Narrative review of unmet needs in clinical practice guidelines 32
The clinical phenotype of Systemic Sclerosis patients with anti-PM/Scl antibodies: results from the EUSTAR cohort 31
Reply to: Anti-carbamylated protein antibodies are associated with early abatacept response in rheumatoid arthritis by Castellanos-Moreira et al 28
Real life picture of the use of intravenous immunoglobulins in idiopathic inflammatory myopathies: Results of a multicentric study 26
Serum IgG2 antibody multicomposition in systemic lupus erythematosus and lupus nephritis (Part 1): cross-sectional analysis 26
An Italian Multicenter Study on Anti-NXP2 Antibodies: Clinical and Serological Associations 26
Second Wave Antibodies in Autoimmune Renal Diseases: The Case of Lupus Nephritis 26
Systematic review and meta-analysis of epidemiological studies on the association of occupational exposure to free crystalline silica and systemic lupus erythematosus 24
Ventricular-arterial coupling in systemic lupus erythematosus women without cardiovascular risk factors 21
Stopping bDMARDs at the beginning of pregnancy is associated with disease flares and preterm delivery in women with rheumatoid arthritis 17
Endothelial Dysfunction in Systemic Lupus Erythematosus and Systemic Sclerosis: A Common Trigger for Different Microvascular Diseases 17
Calprotectin as a biomarker in rheumatoid arthritis: the potential predictive value of response to treatment 14
Efficacy of COVID-19 mRNA vaccination in patients with autoimmune disorders: humoral and cellular immune response 14
Geographical heterogeneity of clinical and serological phenotypes of systemic sclerosis observed at tertiary referral centres. The experience of the Italian SIR-SPRING registry and review of the world literature 13
Impaired immunogenicity to COVID-19 vaccines in autoimmune systemic diseases. High prevalence of non-response in different patients' subgroups 13
Clinical spectrum time course in non-Asian patients positive for anti-MDA5 antibodies 12
Prevalence and death rate of COVID-19 in systemic autoimmune diseases in the first three pandemic waves. Relationship to disease subgroups and ongoing therapies 11
Anti-Th/To antibodies in systemic sclerosis: analysis of long-term follow-up of pulmonary involvement, organ damage accrual and mortality in an Italian cohort with a case-control study 10
Serum IgG2 antibody multi-composition in systemic lupus erythematosus and in lupus nephritis (Part 2): prospective study 9
Totale 9.644
Categoria #
all - tutte 35.381
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.381


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019478 0 0 0 0 0 0 0 0 0 103 183 192
2019/20202.119 310 87 97 209 143 224 201 221 169 250 80 128
2020/20211.726 47 162 96 164 137 183 96 167 197 185 185 107
2021/20221.536 81 185 102 73 113 115 137 109 113 138 141 229
2022/20231.122 142 25 42 40 82 213 36 121 209 47 92 73
2023/2024976 63 45 99 94 73 210 73 59 210 50 0 0
Totale 9.661